
About SRHHL
SRHHL is a publicly listed company based in Kurnool (India) founded in 2005 by T G Venkatesh. Speciality chemicals and alkalies are manufactured and exported by SRHHL. The company has 41 employees. Its Indian entity Sree Rayalaseema Hi-Strength Hypo Limited reported revenue of βΉ722 Cr. SRHHL offers products and services including Sulphuric Acid, Hydrochloric Acid, Chlorosulphonic Acid, Stable Bleaching Powder, and Sodium Methoxide Solution. Its focus areas include Chemicals and Materials, Diversified Chemicals and Diversified.
Company details
SRHHL was established in 2005 by T G Venkatesh in Kurnool, India. Speciality chemicals and alkalies are produced and exported from this location. Operations center on the chemical manufacturing sector, with a focus on industrial applications. Products are distributed to domestic and international markets through export channels. The company maintains its headquarters in Kurnool, supporting regional chemical production needs.
- Headquarters Kurnool, India
- Employees 41
- Founders T G Venkatesh
- Stage Public
- SectorsChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website srhhl.com
- Social LinkedIn
- Legal Name Sree Rayalaseema Hi-Strength Hypo Limited
- Date of Incorporation 28 Mar, 2005
- Jurisdiction Kurnool, Andhra Pradesh, India
- Market Cap₹846 Cr
SRHHYPOLTD · NSE
- Share Price₹492.90
-0.75% today
- Revenue₹667 Cr
FY 2025-26 · +4.6% YoY
- EBITDA₹74.92 Cr
Margin 11.2%
- Net Profit₹99.01 Cr
FY 2025-26 · +7.1% YoY
- P/E (TTM)8.5x
P/B 0.9x
- Employee Count41
Associated legal entities of SRHHL
SRHHL operates through Sree Rayalaseema Hi-Strength Hypo Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sree Rayalaseema Hi-Strength Hypo Limited Listed CIN L24110AP2005PLC045726 | Active | 28 Mar 2005 | Kurnool, Andhra Pradesh | ₹722 Cr | 411 | 8 | View details |
Products & Services of SRHHL
SRHHL offers a comprehensive portfolio of products and services, including Sulphuric Acid, Hydrochloric Acid, Chlorosulphonic Acid, Stable Bleaching Powder, and Sodium Methoxide Solution.
Acid used in industrial processes for manufacturing and refining.
Acid applied in cleaning and chemical production industries.
Acid utilized for sulfonation in pharmaceutical and dye sectors.
Powder for water treatment and disinfection purposes.
Solution used as a catalyst in biodiesel and organic synthesis.
Board of directors of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHL)
Sree Rayalaseema Hi-Strength Hypo Limited is the primary company behind SRHHL. The board of Sree Rayalaseema Hi-Strength Hypo Limited currently have 6 directors; the longest-serving is Gurunatha Reddy Hiregoudara, appointed in 2015. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gurunatha Reddy Hiregoudara DIN 07211326 | Director | 15 Jun 2015 | 11 yrs 4 mo | Sree Rayalaseema Hi-Strength Hypo Limited |
| Agadi Kailashnath DIN 03017003 | Director | 30 May 2016 | 10 yrs 5 mo | Sree Rayalaseema Hi-Strength Hypo Limited |
| Rukmangada Triveni DIN 09045405 | Director | 13 Feb 2021 | 5 yrs 8 mo | Sree Rayalaseema Hi-Strength Hypo Limited |
| Satyam Gadwal DIN 09762624 | Director | 13 Oct 2022 | 4 yrs | Sree Rayalaseema Hi-Strength Hypo Limited |
| Shilpa Bharath Tumbalam Gooty DIN 01895414 | Managing Director | 26 Jun 2024 | 2 yrs 4 mo | Sree Rayalaseema Hi-Strength Hypo Limited |
| Kamma Edlapalli Krishna DIN 11239076 | Director | 14 Aug 2025 | 1 yr 2 mo | Sree Rayalaseema Hi-Strength Hypo Limited |
People of SRHHL
1 people are tracked at SRHHL (1 in leadership); the tracked headcount is 41.
| Name | Role | Group |
|---|---|---|
T G Venkatesh | Founder | Leadership |
Complete people profiles for SRHHL
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of SRHHL
SRHHL is a publicly listed company on the NSE with ticker symbol SRHHYPOLTD in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date11 May 2007
- Listed onNSE: SRHHYPOLTD
- Listed entitySree Rayalaseema Hi-Strength Hypo Limited
- Exchange sectorProcess industries
Financials of SRHHL
Exchange-reported figures of Sree Rayalaseema Hi-Strength Hypo Limited, the listed company behind SRHHL (NSE: SRHHYPOLTD).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 667 | 638 | 866 | 1,650 | 1,267 | 911 | 689 |
| Revenue growth | +4.6% | -26.4% | -47.5% | +30.2% | +39.1% | +32.2% | - |
| EBITDA | 74.92 | 88.98 | 99.70 | 180 | 149 | 130 | 102 |
| EBITDA margin | +11.2% | +14.0% | +11.5% | +10.9% | +11.7% | +14.3% | +14.8% |
| Profit before tax | 121 | 119 | 107 | 190 | 137 | 80.82 | 45.46 |
| Net profit | 99.01 | 92.47 | 87.12 | 142 | 103 | 60.55 | 37.91 |
| Net profit margin | +14.8% | +14.5% | +10.1% | +8.6% | +8.1% | +6.7% | +5.5% |
| EPS (βΉ) | 53.24 | 52.47 | 46.06 | 89.87 | 59.88 | 35.29 | 22.08 |
| Balance sheet | |||||||
| Total assets | - | 954 | 818 | 775 | 603 | 463 | 372 |
| Net worth | - | 918 | 801 | 751 | 570 | 388 | 312 |
| Total debt | - | 15.74 | 12.92 | 19.17 | 28.36 | 71.51 | 57.23 |
| Cash & bank | - | 374 | 334 | 229 | 113 | 139 | 86.43 |
| Net working capital | - | 522 | 476 | 431 | 297 | 258 | 180 |
| Cash flow | |||||||
| Cash from operations | - | 65.48 | 140 | 141 | 59.75 | 70.56 | 99.31 |
| Cash from investing | - | (8.23) | (19.99) | (112) | (1.17) | (115) | (37.60) |
| Cash from financing | - | (17.58) | (16.83) | (16.65) | (51.32) | 10.16 | (21.84) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 211 | 163 | 141 | 182 | 180 | 160 | 138 | 170 |
| Revenue growth (YoY) | +17.0% | +1.7% | +2.0% | +7.1% | +6.9% | - | - | - |
| Other income | 9.87 | 17.90 | 19.40 | 7.10 | 10.39 | 15.33 | 12.56 | 9.13 |
| EBITDA | 26.35 | 7.76 | 17.04 | 26.95 | 23.17 | 14.56 | 19.80 | 28.95 |
| EBITDA margin | +12.5% | +4.8% | +12.1% | +14.8% | +12.9% | +9.1% | +14.3% | +17.0% |
| Depreciation | 1.81 | 1.82 | 1.81 | 1.80 | 1.80 | 1.90 | 1.84 | 1.92 |
| Interest | 0.50 | 0.42 | 0.41 | 0.42 | 0.42 | 0.69 | 0.37 | 0.32 |
| Profit before tax | 33.91 | 23.42 | 34.22 | 31.83 | 31.34 | 27.30 | 30.15 | 35.84 |
| Tax | 9.17 | 3.37 | 10.47 | 8.54 | 8.92 | 5.31 | 8.60 | 10.54 |
| Net profit | 24.74 | 20.05 | 23.75 | 23.29 | 22.42 | 21.99 | 21.55 | 25.30 |
| EPS (βΉ) | 14.53 | 11.83 | (14.04) | 13.57 | 13.06 | 12.81 | 12.56 | 14.74 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 667 | 638 | 866 | 1,650 | 1,267 | 911 | 689 |
| Revenue growth | +4.6% | -26.4% | -47.5% | +30.2% | +39.1% | +32.2% | - |
| EBITDA | 75.74 | 92.55 | 99.79 | 180 | 149 | 130 | 102 |
| EBITDA margin | +11.4% | +14.5% | +11.5% | +10.9% | +11.7% | +14.3% | +14.8% |
| Profit before tax | 123 | 124 | 109 | 190 | 137 | 80.85 | 45.46 |
| Net profit | 103 | 95.10 | 88.53 | 142 | 103 | 60.58 | 37.91 |
| Net profit margin | +15.4% | +14.9% | +10.2% | +8.6% | +8.1% | +6.7% | +5.5% |
| EPS (βΉ) | 53.97 | 53.99 | 46.85 | 89.90 | 59.88 | 35.30 | 22.09 |
| Balance sheet | |||||||
| Total assets | - | 943 | 812 | 771 | 603 | 463 | 372 |
| Net worth | - | 922 | 802 | 751 | 570 | 388 | 312 |
| Total debt | - | 15.45 | 4.91 | 15.97 | 28.06 | 71.51 | 57.23 |
| Cash & bank | - | 373 | 334 | 229 | 113 | 139 | 86.42 |
| Net working capital | - | 517 | 494 | 441 | 297 | 258 | 180 |
| Cash flow | |||||||
| Cash from operations | - | 87.75 | 132 | 131 | 60.11 | 70.54 | 99.31 |
| Cash from investing | - | (40.44) | (7.89) | (98.62) | (1.20) | (115) | (37.61) |
| Cash from financing | - | (8.25) | (21.63) | (19.96) | (51.62) | 10.16 | (21.84) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 211 | 163 | 141 | 182 | 180 | 160 | 138 | 170 |
| Revenue growth (YoY) | +17.0% | +1.7% | +2.0% | +7.1% | +6.9% | - | - | - |
| Other income | 9.88 | 17.92 | 19.45 | 7.08 | 10.40 | 15.33 | 12.56 | 8.70 |
| Total expenses | 185 | 155 | 124 | 155 | 157 | 146 | 117 | 140 |
| EBITDA | 26.37 | 7.84 | 17.15 | 27.01 | 23.74 | 14.87 | 21.36 | 29.79 |
| EBITDA margin | +12.5% | +4.8% | +12.1% | +14.8% | +13.2% | +9.3% | +15.4% | +17.5% |
| Depreciation | 1.41 | 1.41 | 1.41 | 1.40 | 1.40 | 1.49 | 1.43 | 1.52 |
| Interest | 0.50 | 0.42 | 0.41 | 0.42 | 0.42 | 0.69 | 0.37 | 0.49 |
| Profit before tax | 34.34 | 23.93 | 34.78 | 32.27 | 32.32 | 28.02 | 32.12 | 36.48 |
| Tax | 9.17 | 3.37 | 10.47 | 7.90 | 8.92 | 5.31 | 8.60 | 10.54 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 211 | 163 | 141 | 182 | 180 | 160 | 138 | 170 |
| Revenue growth (YoY) | +17.0% | +1.7% | +2.0% | +7.1% | +6.9% | - | - | - |
| Other income | 9.87 | 17.90 | 19.40 | 7.10 | 10.39 | 15.33 | 12.56 | 9.13 |
| EBITDA | 26.35 | 7.76 | 17.04 | 26.95 | 23.17 | 14.56 | 19.80 | 28.95 |
| EBITDA margin | +12.5% | +4.8% | +12.1% | +14.8% | +12.9% | +9.1% | +14.3% | +17.0% |
| Depreciation | 1.81 | 1.82 | 1.81 | 1.80 | 1.80 | 1.90 | 1.84 | 1.92 |
| Interest | 0.50 | 0.42 | 0.41 | 0.42 | 0.42 | 0.69 | 0.37 | 0.32 |
| Profit before tax | 33.91 | 23.42 | 34.22 | 31.83 | 31.34 | 27.30 | 30.15 | 35.84 |
| Tax | 9.17 | 3.37 | 10.47 | 8.54 | 8.92 | 5.31 | 8.60 | 10.54 |
| Net profit | 24.74 | 20.05 | 23.75 | 23.29 | 22.42 | 21.99 | 21.55 | 25.30 |
| EPS (βΉ) | 14.53 | 11.83 | (14.04) | 13.57 | 13.06 | 12.81 | 12.56 | 14.74 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 667 | 638 | 866 | 1,650 | 1,267 | 911 | 689 |
| Revenue growth | +4.6% | -26.4% | -47.5% | +30.2% | +39.1% | +32.2% | - |
| Other income | 54.79 | 39.47 | 22.15 | 34.11 | 10.68 | 6.63 | 3.92 |
| Total expenses | 592 | 549 | 766 | 1,470 | 1,119 | 781 | 587 |
| Employee cost | 0.00 | 34.37 | 35.14 | 38.81 | 28.74 | 25.45 | 22.53 |
| EBITDA | 74.92 | 88.98 | 99.70 | 180 | 149 | 130 | 102 |
| EBITDA margin | +11.2% | +14.0% | +11.5% | +10.9% | +11.7% | +14.3% | +14.8% |
| Depreciation | 7.24 | 7.32 | 10.60 | 19.35 | 19.23 | 50.61 | 50.27 |
| Interest | 1.68 | 1.98 | 3.98 | 4.75 | 3.21 | 5.48 | 10.16 |
| Profit before tax | 121 | 119 | 107 | 190 | 137 | 80.82 | 45.46 |
| Tax | 30.65 | 31.68 | 28.31 | 36.17 | 34.20 | 20.27 | 7.54 |
| Net profit | 99.01 | 92.47 | 87.12 | 142 | 103 | 60.55 | 37.91 |
| Net profit margin | +14.8% | +14.5% | +10.1% | +8.6% | +8.1% | +6.7% | +5.5% |
| EPS (βΉ) | 53.24 | 52.47 | 46.06 | 89.87 | 59.88 | 35.29 | 22.08 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 17.16 | 17.16 | 17.16 | 17.16 | 17.16 | 17.16 |
| Reserves & surplus | - | 901 | 783 | 734 | 553 | 371 | 294 |
| Shareholders' funds (net worth) | - | 918 | 801 | 751 | 570 | 388 | 312 |
| Minority interest | - | 14.47 | 0.07 | 0.16 | 0.03 | 0.00 | 0.00 |
| Secured loans | - | 1.61 | 8.01 | 11.90 | 19.10 | 61.34 | 45.38 |
| Unsecured loans | - | 14.13 | 4.91 | 7.27 | 9.26 | 10.17 | 11.85 |
| Total debt | - | 15.74 | 12.92 | 19.17 | 28.36 | 71.51 | 57.23 |
| Total liabilities | - | 954 | 818 | 775 | 603 | 463 | 372 |
| Assets | |||||||
| Gross block | - | 477 | 470 | 437 | 466 | 429 | 406 |
| Net block | - | 135 | 128 | 105 | 130 | 134 | 161 |
| Capital work in progress | - | 0.00 | 0.00 | 13.61 | 0.05 | 0.44 | 3.05 |
| Investments | - | 349 | 253 | 268 | 164 | 50.34 | 18.43 |
| Inventories | - | 39.73 | 31.69 | 126 | 144 | 39.71 | 36.71 |
| Sundry debtors | - | 103 | 107 | 149 | 132 | 96.60 | 82.03 |
| Cash & bank balances | - | 374 | 334 | 229 | 113 | 139 | 86.43 |
| Loans & advances | - | 64.49 | 56.76 | 50.19 | 92.36 | 39.29 | 42.45 |
| Total current assets | - | 581 | 529 | 554 | 482 | 314 | 248 |
| Total current liabilities | - | 59.42 | 53.03 | 123 | 185 | 55.90 | 68.11 |
| Net working capital | - | 522 | 476 | 431 | 297 | 258 | 180 |
| Total assets | - | 954 | 818 | 775 | 603 | 463 | 372 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 329 | 226 | 214 | 6.99 | 41.65 | 1.78 |
| Net cash from operating activities | - | 65.48 | 140 | 141 | 59.75 | 70.56 | 99.31 |
| Net cash from investing activities | - | (8.23) | (19.99) | (112) | (1.17) | (115) | (37.60) |
| Net cash from financing activities | - | (17.58) | (16.83) | (16.65) | (51.32) | 10.16 | (21.84) |
| Net change in cash | - | 39.67 | 103 | 12.51 | 7.26 | (34.66) | 39.87 |
| Closing cash | - | 374 | 334 | 229 | 113 | 139 | 86.43 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +4.6% | -26.4% | -47.5% | +30.2% | +39.1% | +32.2% | - |
| EBITDA growth | -15.8% | -10.8% | -44.7% | +21.3% | +14.2% | +27.8% | - |
| PBT growth | +1.4% | +11.1% | -43.7% | +39.0% | +69.5% | +77.8% | +425.6% |
| Net income growth | +7.1% | +6.1% | -38.8% | +38.5% | +69.7% | +59.7% | - |
| Revenue CAGR (3Y) | -26.1% | -20.5% | -1.7% | +33.8% | +97.6% | +35.8% | - |
| EBITDA CAGR (3Y) | -25.4% | -15.7% | -8.5% | +21.0% | +89.6% | +44.8% | - |
| Profitability & leverage | |||||||
| Net income margin | +13.5% | +13.7% | +9.1% | +9.4% | +8.1% | +6.7% | +5.5% |
| Return on capital employed | - | +13.8% | +15.3% | +28.3% | +26.3% | +20.7% | +15.0% |
| Return on net worth | - | +10.2% | +11.2% | +23.4% | +21.5% | +17.3% | +12.2% |
| Debt / equity | - | 0.02 | 0.02 | 0.04 | 0.10 | 0.18 | 0.18 |
| Long-term debt / equity | - | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 |
| Interest cover | 2.48 | 2.42 | 4.47 | 2.95 | 2.48 | 6.88 | 19.65 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 1.35 | 1.91 | 3.65 | 2.83 | 2.18 | 1.70 |
| Inventory turnover | - | 17.86 | 11.00 | 12.23 | 13.80 | 23.84 | 18.77 |
| Debtors turnover | - | 6.07 | 6.77 | 11.74 | 11.08 | 10.20 | 8.40 |
| EPS (βΉ) | 53.24 | 52.47 | 46.06 | 89.87 | 59.88 | 35.29 | 22.08 |
| Dividend per share (βΉ) | 3.00 | 3.00 | 3.00 | 4.00 | 3.50 | 3.00 | 2.50 |
| Book value per share (βΉ) | 0.00 | 534.98 | 466.43 | 437.48 | 332.24 | 226.03 | 181.51 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 211 | 163 | 141 | 182 | 180 | 160 | 138 | 170 |
| Revenue growth (YoY) | +17.0% | +1.7% | +2.0% | +7.1% | +6.9% | - | - | - |
| Other income | 9.88 | 17.92 | 19.45 | 7.08 | 10.40 | 15.33 | 12.56 | 8.70 |
| Total expenses | 185 | 155 | 124 | 155 | 157 | 146 | 117 | 140 |
| EBITDA | 26.37 | 7.84 | 17.15 | 27.01 | 23.74 | 14.87 | 21.36 | 29.79 |
| EBITDA margin | +12.5% | +4.8% | +12.1% | +14.8% | +13.2% | +9.3% | +15.4% | +17.5% |
| Depreciation | 1.41 | 1.41 | 1.41 | 1.40 | 1.40 | 1.49 | 1.43 | 1.52 |
| Interest | 0.50 | 0.42 | 0.41 | 0.42 | 0.42 | 0.69 | 0.37 | 0.49 |
| Profit before tax | 34.34 | 23.93 | 34.78 | 32.27 | 32.32 | 28.02 | 32.12 | 36.48 |
| Tax | 9.17 | 3.37 | 10.47 | 7.90 | 8.92 | 5.31 | 8.60 | 10.54 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 667 | 638 | 866 | 1,650 | 1,267 | 911 | 689 |
| Revenue growth | +4.6% | -26.4% | -47.5% | +30.2% | +39.1% | +32.2% | - |
| Other income | 54.86 | 39.47 | 23.50 | 34.11 | 10.66 | 6.63 | 3.92 |
| Total expenses | 591 | 545 | 766 | 1,470 | 1,118 | 781 | 587 |
| Employee cost | 0.00 | 34.14 | 35.07 | 38.78 | 28.74 | 25.45 | 22.53 |
| EBITDA | 75.74 | 92.55 | 99.79 | 180 | 149 | 130 | 102 |
| EBITDA margin | +11.4% | +14.5% | +11.5% | +10.9% | +11.7% | +14.3% | +14.8% |
| Depreciation | 5.62 | 5.70 | 10.58 | 19.35 | 19.23 | 50.61 | 50.27 |
| Interest | 1.68 | 1.98 | 3.98 | 4.75 | 3.21 | 5.48 | 10.16 |
| Profit before tax | 123 | 124 | 109 | 190 | 137 | 80.85 | 45.46 |
| Tax | 30.65 | 31.68 | 28.31 | 36.17 | 34.20 | 20.27 | 7.54 |
| Net profit | 103 | 95.10 | 88.53 | 142 | 103 | 60.58 | 37.91 |
| Net profit margin | +15.4% | +14.9% | +10.2% | +8.6% | +8.1% | +6.7% | +5.5% |
| EPS (βΉ) | 53.97 | 53.99 | 46.85 | 89.90 | 59.88 | 35.30 | 22.09 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 17.16 | 17.16 | 17.16 | 17.16 | 17.16 | 17.16 |
| Reserves & surplus | - | 905 | 785 | 734 | 553 | 371 | 294 |
| Shareholders' funds (net worth) | - | 922 | 802 | 751 | 570 | 388 | 312 |
| Secured loans | - | 1.32 | 0.00 | 8.70 | 18.80 | 61.34 | 45.38 |
| Unsecured loans | - | 14.13 | 4.91 | 7.27 | 9.26 | 10.17 | 11.85 |
| Total debt | - | 15.45 | 4.91 | 15.97 | 28.06 | 71.51 | 57.23 |
| Total liabilities | - | 943 | 812 | 771 | 603 | 463 | 372 |
| Assets | |||||||
| Gross block | - | 453 | 446 | 437 | 443 | 429 | 406 |
| Net block | - | 112 | 103 | 105 | 130 | 134 | 161 |
| Capital work in progress | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.44 | 3.05 |
| Investments | - | 366 | 253 | 268 | 164 | 50.45 | 18.44 |
| Inventories | - | 39.15 | 31.56 | 126 | 144 | 39.71 | 36.71 |
| Sundry debtors | - | 103 | 107 | 149 | 132 | 96.60 | 82.03 |
| Cash & bank balances | - | 373 | 334 | 229 | 113 | 139 | 86.42 |
| Loans & advances | - | 60.43 | 74.14 | 59.96 | 92.36 | 39.29 | 42.45 |
| Total current assets | - | 576 | 546 | 563 | 482 | 314 | 248 |
| Total current liabilities | - | 59.16 | 52.59 | 122 | 185 | 55.83 | 68.11 |
| Net working capital | - | 517 | 494 | 441 | 297 | 258 | 180 |
| Total assets | - | 943 | 812 | 771 | 603 | 463 | 372 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 329 | 226 | 214 | 6.86 | 41.64 | 1.78 |
| Net cash from operating activities | - | 87.75 | 132 | 131 | 60.11 | 70.54 | 99.31 |
| Net cash from investing activities | - | (40.44) | (7.89) | (98.62) | (1.20) | (115) | (37.61) |
| Net cash from financing activities | - | (8.25) | (21.63) | (19.96) | (51.62) | 10.16 | (21.84) |
| Net change in cash | - | 39.06 | 103 | 12.36 | 7.28 | (34.78) | 39.86 |
| Closing cash | - | 373 | 334 | 229 | 113 | 139 | 86.42 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +4.6% | -26.4% | -47.5% | +30.2% | +39.1% | +32.2% | - |
| EBITDA growth | -18.2% | -7.3% | -44.7% | +21.3% | +14.2% | +27.8% | - |
| PBT growth | -0.8% | +14.4% | -42.9% | +39.1% | +69.4% | +77.9% | +7.7% |
| Net income growth | +8.1% | +7.4% | -37.8% | +38.6% | +69.6% | +59.8% | - |
| Revenue CAGR (3Y) | -26.1% | -20.5% | -1.7% | +33.8% | +21.8% | +18.6% | +23.4% |
| EBITDA CAGR (3Y) | -25.1% | -14.6% | -8.5% | +21.0% | +14.8% | +41.7% | +30.7% |
| Profitability & leverage | |||||||
| Net income margin | +13.9% | +14.5% | +9.3% | +9.4% | +8.1% | +6.7% | +5.5% |
| Return on capital employed | - | +14.4% | +14.2% | +28.4% | +26.3% | +20.7% | +14.8% |
| Return on net worth | - | +10.8% | +10.4% | +23.4% | +21.5% | +17.3% | +11.9% |
| Debt / equity | - | 0.01 | 0.01 | 0.03 | 0.10 | 0.18 | 0.17 |
| Long-term debt / equity | - | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 |
| Interest cover | 2.40 | 2.28 | 4.46 | 2.95 | 2.48 | 6.88 | 19.65 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 1.42 | 1.96 | 3.75 | 2.91 | 2.18 | 1.73 |
| Inventory turnover | - | 18.04 | 11.01 | 12.23 | 13.80 | 23.84 | 18.68 |
| Debtors turnover | - | 6.07 | 6.77 | 11.74 | 11.08 | 10.20 | 8.11 |
| EPS (βΉ) | 53.97 | 53.99 | 46.85 | 89.90 | 59.88 | 35.30 | 22.09 |
| Dividend per share (βΉ) | 3.00 | 3.00 | 3.00 | 4.00 | 3.50 | 3.00 | 2.50 |
| Book value per share (βΉ) | 0.00 | 537.34 | 467.27 | 437.55 | 332.26 | 226.05 | 181.51 |
Web traffic of SRHHL
The website of SRHHL (srhhl.com) receives about 6.3K visits a month.
- Monthly visits6.3K
▲ 164.5% vs previous month
Top companies in Core & Diversified Chemicals
3 companies that operate in the same segment as SRHHL (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate | 1979 | Pune, Maharashtra, India | USD 1.21 B | 1,020 | ||
Specialty chemicals are manufactured through integrated R&D and production processes. | 2023 | Bengaluru, Karnataka, India | USD 72.97 M | USD 23.86 M | ||
Manufactures coal tar and basic industrial chemicals. | 1987 | Kolkata, West Bengal, India | USD 24 M | USD 515.01 M | 1,161 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Srhhl
Complete news archive for SRHHL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SRHHL
SRHHL was founded in 2005.
SRHHL is headquartered in Kurnool, India. It is registered at Kurnool, Andhra Pradesh, India.
SRHHL has 41 employees.
The primary company behind SRHHL, Sree Rayalaseema Hi-Strength Hypo Limited, reported revenue of βΉ722 Cr for FY 2026, up 5% year on year.
SRHHL was established in 2005 by T G Venkatesh in Kurnool, India. Speciality chemicals and alkalies are produced and exported from this location. Operations center on the chemical manufacturing sector, with a focus on industrial applications. Products are distributed to domestic and international markets through export channels. The company maintains its headquarters in Kurnool, supporting regional chemical production needs.
SRHHL offers Sulphuric Acid, Hydrochloric Acid, Chlorosulphonic Acid, Stable Bleaching Powder, and Sodium Methoxide Solution.
Yes, SRHHL is publicly traded on NSE under the ticker symbol SRHHYPOLTD.
SRHHL operates through Sree Rayalaseema Hi-Strength Hypo Limited.
The legal entities of SRHHL currently have 8 directors, including Shilpa Bharath Tumbalam Gooty, Agadi Kailashnath, Gurunatha Reddy Hiregoudara and others.
